What is it about?
We assessed moxifloxacin activity against anaerobes isolated from blood. 81% of Bacteroides spp. and 48% of anaerobes other than Bacteroides were resistant to moxifloxacin (EUCAST criteria). 41% of Bacteroides spp. and 35% of anaerobes other than Bacteroides were resistant to moxifloxacin (CLSI criteria).
Featured Image
Photo by Alexander Grey on Unsplash
Why is it important?
We reported an alarming increase in moxifloxacin resistance among anaerobes in Italy.
Read the Original
This page is a summary of: Time to reconsider moxifloxacin anti-anaerobic activity?, Journal of Chemotherapy, August 2022, Taylor & Francis,
DOI: 10.1080/1120009x.2022.2106637.
You can read the full text:
Contributors
The following have contributed to this page
